Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
Zhi‐Ming Shao(Fudan University), Jiong Wu(Shanghai Medical College of Fudan University)
Cited by 21
Related Papers
LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription
|Molecular Cancer|2019|220
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
|Nature Communications|2018|183
Tumor Associated Macrophage × Cancer Cell Hybrids May Acquire Cancer Stem Cell Properties in Breast Cancer
|PLoS ONE|2012|124
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2021|55